Literature DB >> 11307970

Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man.

J J Bogaards1, M Bertrand, P Jackson, M J Oudshoorn, R J Weaver, P J van Bladeren, B Walther.   

Abstract

1. In the present study, nine cytochrome P450 enzyme activities in seven species were characterized to allow a practical means of comparing this important metabolic step between various test animals and man. 2. Enzyme activities and kinetic parameters were first determined towards marker substrates for human cytochrome P450 enzymes. Inhibition profiles were then determined with both antibodies directed against various cytochrome P450 enzymes and with chemical inhibitors. 3. Both the enzyme kinetic parameters/enzyme activities, and the inhibition profiles obtained for the animal species were compared with those obtained for human liver microsomes in order to postulate the animal species most similar to man with regard to each individual cytochrome P450 enzyme activity. 4. It was found that, as expected, none of the tested species was similar to man for all the measured P450 enzyme activities, but that in each species only some of the P450 enzyme activities could be considered as similar to man. 5. When it is known which human cytochrome P450 enzymes are involved in the metabolism of a compound, the comparative data presented here can be used for selecting the most suitable species for in vitro and in it no experiments.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11307970     DOI: 10.1080/00498250010021684

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  57 in total

1.  Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice.

Authors:  Yuki Kutsuno; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

2.  Effects of ketoconazole on the biodistribution and metabolism of [11C]loperamide and [11C]N-desmethyl-loperamide in wild-type and P-gp knockout mice.

Authors:  Nicholas Seneca; Sami S Zoghbi; H Umesha Shetty; Edward Tuan; Pavitra Kannan; Andrew Taku; Robert B Innis; Victor W Pike
Journal:  Nucl Med Biol       Date:  2010-04       Impact factor: 2.408

Review 3.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

4.  Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasia.

Authors:  Bo Jiang; Alok R Khandelwal; Lynette K Rogers; Valeria Y Hebert; James J Kleinedler; James H Zavecz; Weibin Shi; A Wayne Orr; Tammy R Dugas
Journal:  Toxicol Sci       Date:  2010-07-09       Impact factor: 4.849

Review 5.  A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.

Authors:  Claudia Suenderhauf; Neil Parrott
Journal:  Pharm Res       Date:  2012-11-21       Impact factor: 4.200

6.  Metabolomics reveals the metabolic map of procainamide in humans and mice.

Authors:  Fei Li; Andrew D Patterson; Kristopher W Krausz; Bernhard Dick; Felix J Frey; Frank J Gonzalez; Jeffrey R Idle
Journal:  Biochem Pharmacol       Date:  2012-02-24       Impact factor: 5.858

7.  Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine.

Authors:  Cheng Li; Dong-Hyun Choi; Jun-Shik Choi
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-01       Impact factor: 2.745

8.  Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.

Authors:  Cheng Li; Sung-Cil Lim; Jin Kim; Jun-Shik Choi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-03-27       Impact factor: 2.441

9.  Bama miniature pigs (Sus scrofa domestica) as a model for drug evaluation for humans: comparison of in vitro metabolism and in vivo pharmacokinetics of lovastatin.

Authors:  Yu Liu; Ben-Hua Zeng; Hai-Tao Shang; Yan-Yan Cen; Hong Wei
Journal:  Comp Med       Date:  2008-12       Impact factor: 0.982

10.  A human hepatocyte-bearing mouse: an animal model to predict drug metabolism and effectiveness in humans.

Authors:  Katsutoshi Yoshizato; Chise Tateno
Journal:  PPAR Res       Date:  2009-10-26       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.